- Home
- ROIV vs ALV Comparison
ROIV vs ALV Comparison
Compare ROIV & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | ALV |
|---|---|---|
| Founded | 2014 | 1953 |
| Country | United Kingdom | Sweden |
| Employees | N/A | 65200 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 8.9B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | ALV |
|---|---|---|
| Price | $27.34 | $105.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | $27.56 | ★ $137.10 |
| AVG Volume (30 Days) | ★ 4.4M | 650.4K |
| Earning Date | 02-06-2026 | 04-17-2026 |
| Dividend Yield | N/A | ★ 3.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,053,000.00 | N/A |
| Revenue This Year | N/A | $2.76 |
| Revenue Next Year | $594.84 | $3.52 |
| P/E Ratio | ★ N/A | $13.10 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $75.49 |
| 52 Week High | $30.33 | $130.14 |
Technical Indicators
Market Signals| Indicator | ROIV | ALV |
|---|---|---|
| Relative Strength Index (RSI) | 48.24 | 37.49 |
| Support Level | $26.94 | N/A |
| Resistance Level | $27.94 | $128.33 |
| Average True Range (ATR) | 0.89 | 2.25 |
| MACD | -0.38 | 0.26 |
| Stochastic Oscillator | 20.19 | 51.47 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About ALV Autoliv Inc.
Autoliv Inc is a developer, manufacturer, and supplier of passive safety systems to the automotive industry with a broad range of product offerings. Its product portfolio includes passive safety systems for commercial vehicles, battery cut-off switches, safety solutions for riders of motorcycles and bikes, airbags (including steering wheels and inflators), seatbelts, etc. Geographically, the group operates in the Americas, Europe, China, and Asia, excluding China, of which the maximum revenue is generated from its business in the Americas.